JHF, JFilm Partner to Raise Awareness of BRCA Cancer Risks, Treatment Options

Updated on September 29, 2016

Over the next year, JHF will partner with JFilm and the producers of “Pink and Blue: Colors of Hereditary Cancer” to make the film available to audiences throughout the Pittsburgh region. The first film screening will be held during Breast Cancer Awareness Month on Thursday, October 13 at 7 pm at UPMC Magee-Women’s Hospital (Auditorium level).

“Pink and Blue” explores the clinical, social, and familial implications of BRCA1 and BRCA2 genetic mutations, which put both women and men at a higher risk of developing numerous cancers.

Without treatment, women who have a BRCA genetic mutation are seven times more likely to develop breast cancer and 30 times more likely to develop ovarian cancer by the age of 70, according to the Centers for Disease Control and Prevention. BRCA mutations may also increase the risk of pancreatic, prostate, and breast cancer among men. Ashkenazi Jews are at a higher risk of possessing BRCA genetic mutations than the general population.

To RSVP for the October 13 film screening, contact Administrative Coordinator Ben Johnston ([email protected])

Throughout the year, our writers feature fresh, in-depth, and relevant information for our audience of 40,000+ healthcare leaders and professionals. As a healthcare business publication, we cover and cherish our relationship with the entire health care industry including administrators, nurses, physicians, physical therapists, pharmacists, and more. We cover a broad spectrum from hospitals to medical offices to outpatient services to eye surgery centers to university settings. We focus on rehabilitation, nursing homes, home care, hospice as well as men’s health, women’s heath, and pediatrics.